TransMedics Group, Inc. operates as a commercial stage medical technology company. The firm engages in the development and commercialization of organ care system platform. It focuses on the preservation of human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation. The company was founded by Waleed H. Hassanein in August 1998 and is headquartered in Andover, MA.
Sector:
Health Technology
Industry:
Medical Specialties
Employees:
898
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Transmedics Group Inc market cap is $2.96B.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Transmedics Group Inc 52 week high is $156.00 as of November 22, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Transmedics Group Inc 52 week low is $60.11 as of November 22, 2026.
Transmedics Group Inc stock price today is $85.25.
Transmedics Group Inc stock price yesterday was $94.02.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Transmedics Group Inc's P/E ratio is 23.37.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Transmedics Group Inc P/B ratio is 5.375.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Transmedics Group Inc 50-day moving average is $80.88.